Protective effects of nanostructures of hydrated C60 fullerene on reproductive function in streptozotocin-diabetic male rats

Toxicology

Volumn 282, Issue 3, 2011, Pages 69-81

  Bal, Ramazan ^a   Türk, Gaffari ^a   Tuzcu, Mehmet ^a   Yilmaz, Okkes ^a   Ozercan, Ibrahim ^a   Kuloglu, Tuncay ^a   Gür, Seyfettin ^a   Nedzvetsky, Victor S ^b   Tykhomyrov, Artem A ^c   Andrievsky, Grigory V ^c   Baydas, Giyasettin ^d   Naziroglu, Mustafa ^e  

^a FIRAT UNIVERSITY   (Turkey)

^b OLES HONCHAR DNIPRO NATIONAL UNIVERSITY   (Ukraine)

^c Institute of Physiologically Active Compounds LLC   (Ukraine)

^d BINGOL UNIVERSITY   (Turkey)

^e SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Apoptosis; Diabetes mellitus; Fatty acid composition; Hydrated C60 fullerene; Oxidative stress; Sperm characteristics; Streptozotocin; Testis

Indexed keywords

ALPHA TOCOPHEROL; DRINKING WATER; EOSIN; FULLERENE; GLUTATHIONE; HEMATOXYLIN; NANOMATERIAL; POLYUNSATURATED FATTY ACID; STREPTOZOCIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; DESQUAMATION; DRUG EFFECT; EDEMA; EPIDIDYMIS; GERM CELL; HISTOPATHOLOGY; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE; RAT; REPRODUCTION; SEMINAL VESICLE; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; STREPTOZOCIN DIABETES; TESTIS; TESTIS DISEASE; TESTOSTERONE BLOOD LEVEL; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOOD GLUCOSE; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; EPIDIDYMIS; FATTY ACIDS; FULLERENES; IN SITU NICK-END LABELING; INFERTILITY, MALE; MALE; NANOSTRUCTURES; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPRODUCTION; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; STREPTOZOCIN; TESTIS; TESTOSTERONE; WATER;

ANIMALIA; RATTUS;

EID: 79952313450     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.12.003     Document Type: Article

References (104)

1. Agarwal A., Makker K., Sharma R. Clinical relevance of oxidative stress in male factor infertility, an update. Am. J. Reprod. Immunol. 2008, 59:2-11.
2. Akerboom T.D.M., Sies H. Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples. Method Enzymol. 1981, 77:373-382.
3. Anderson J.E., Thliveris J.A. Testicular histology in streptozotocin-induced diabetes. Anat. Rec. 1986, 214. 378-82.
4. Andrievsky G.V., Kosevich M.V., Vovk O.M., Shelkovsky V.S., Vashchenko L.A. On the production of an aqueous colloidal solution of fullerenes. J. Chem. Soc. Chem. Commun. 1995, 12:1281-1282.
5. Andrievsky G.V., Klochkov V.K., Karyakina E.L., Mchedlov-Petrossyan N.O. Studies of aqueous colloidal solution of fullerene C60 by electron microscopy. Chem. Phys. Lett. 1999, 300:392-396.
6. Andrievsky G.V., Klochkov V.K., Bordyuh A., Dovbeshko G.I. Comparative analysis of two aqueous-colloidal solutions of C60 fullerene with help of FT-IR reflectance and UV-vis spectroscopy. Chem. Phys. Lett. 2002, 364:8-17.
7. Andrievsky G.V., Klochkov V.K., Derevyanchenko L.I. Is C60 fullerene molecule toxic?!. Fullerenes Nanotubes Carbon Nanostruct. 2005, 13:363-376.
8. Andrievsky G.V., Bruskov V.I., Tykhomyrov A.A., Gudkov S.V. Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo. Free Radical Biol. Med. 2009, 47. 786-93.
9. Andrievsky G., Shakhnin D., Tronza A., Zhernosekov D., Tykhomyrov A. The acceleration of blood plasma clot lysis in the presence of hydrated C60 fullerene nanostructures in super-small concentration. Fullerenes Nanotubes Carbon Nanostruct. 2010, 18:303-311.
10. Avdeev M.V., Khokhryakov A.A., Tropin T.V., Andrievsky G.V., Klochkov V.K., Derevyanchenko L.I., Rosta L., Garamus V.M., Priezzhev V.B., Korobov M.V., Aksenov V.L. Structural features of molecular-colloidal solutions of C60 fullerenes in water by small-angle neutron scattering. Langmuir 2004, 20:4363-4368.
11. Ballester J., Munoz M.C., Dominguez J., Rigau T., Guinovart J.J., Rodriguez-Gil J.E. Insulin-dependent diabetes affects testicular function by FSH and LH-linked mechanisms. J. Androl. 2004, 25:706-719.
12. Baydas G., Reiter R.J., Yasar A., Tuscu M., Akdemir I., Nedzvetskii V. Melatonin reduces glial reactivity in the hippocampus, cortex and cerebellum of streptozotocin-induced diabetic rats. Free Radical Biol. Med. 2003, 35:797-804.
13. Beuerle F., Lebovitz R., Hirsch A. Antioxidant properties of water-soluble fullerene derivates. Med. Chem. Pharm. Potent. Fullerene Carbon Nanotubes Carbon Mater.: Chem. Phys. 2008, 1:51-78.
14. Bosi S., Da Ros T., Spalluto G., Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur. J. Med. Chem. 2003, 38:913-923.
15. Brentjens R., Saltz L. Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg. Clin. N. Am. 2001, 81:527-542.
16. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
17. Cai L., Chen S., Evans T., Deng D.X., Mukherjee K., Chakrabarti S. Apoptotic germ-cell death and testicular damage in experimental diabetes, prevention by endothelin antagonism. Urol. Res. 2000, 28:342-347.
18. Cai X., Jia H., Liu Z., Hou B., Luo C., Feng Z., Li W., Liu J. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+)-induced cellular model of Parkinson's disease. J. Neurosci. Res. 2008, 86:3622-3634.
19. Cameron D.F., Murray F.T., Drylie D.D. Interstitial compartment pathology and spermatogenic disruption in testes from impotent diabetic men. Anat. Rec. 1985, 213:53-62.
20. Castro A.C., Berndtson W.E., Cardoso F.M. Plasma and testicular testosterone levels, volume density and number of Leydig cells and spermatogenic efficiency of rabbits. Brazil. J. Med. Biol. Res. 2002, 35:493-498.
21. Chandel A., Dhindsa S., Topiwala S., Chaudhuri A., Dandona P. Testosterone concentration in young patients with diabetes. Diab. Care 2008, 31:2013-2017.
22. Chandrashekar K.N., Muralidhara Evidence of oxidative stress and mitochondrial dysfunctions in the testis of prepubertal diabetic rats. Int. J. Impot. Res. 2009, 21:198-206.
23. Christie W.W. Gas Chromatography and Lipids 1992, The Oil Press, Glaskow.
24. Coniglio J.G., Whorton A.R., Beckman J.K. Essential fatty acids in testes. Adv. Exp. Med. Biol. 1977, 83:575-589.
25. Cummins J.M., Jequier A.M., Kan R. Molecular biology of human male infertility, links with aging, mitochondrial genetics and oxidative stress?. Mol. Reprod. Dev. 1994, 37:345-362.
26. Dawson E.B., Harris W.A., Teter M.C., Powell L.C. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil. Steril. 1992, 58:1034-1039.
27. Dellinger A., Zhou Z., Lenk R., MacFarland D., Kepley C.L. Fullerene nanomaterials inhibit phorbol myristate acecate-induced inflammation. Exp. Dermatol. 2009, 18:1079-1081.
28. Dugan L.L., Gabrielsen J.K., Yu S.P., Lin T.S., Choi D.W. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 1996, 3:129-135.
29. Dugan L.L., Lovett E.G., Quick K.L., Lotharius J., Lin T.T., O'Malley K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 2001, 7:243-246.
30. Duthie G.G., McPhail D.B., Morrice P.C., Arthur J.R. Dietary vitamin E decreases ESR signal intensity in hepatic microsomal preparations from malignant hyperthermia susceptible pigs. Free Radical Res. Commun. 1991, 14:133-137.
31. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
32. Fuller C.J., Chandalia M., Garg A. RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus. Am. J. Clin. Nutr. 1996, 63:753-759.
33. Fumelli C., Marconi A., Salvioli S., Straface E., Malorni W., Offidani A.M., Pellicciari R., Schettini G., Giannetti A., Monti D., Franceschi C., Pincelli C. Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis. J. Invest. Dermatol. 2000, 115:835-841.
34. Gavazza M., Catalá A. The effect of α-tocopherol on the lipid peroxidation of mitochondria and microsomes obtained from rat liver and testis. Mol. Cell Biochem. 2001, 225:121-128.
35. Gharbi N., Pressac M., Hadchouel M., Szwarc H., Wilson S.R., Moussa F. Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005, 5:2578-2585.
36. Ghosh D., Das U.B., Misro M. Protective role of alpha-tocopherol-succinate (provitamin-E) in cyclophosphamide induced testicular gametogenic and steroidogenic disorders, a correlative approach to oxidative stress. Free Radical Res. 2002, 36:1209-1218.
37. Guneli E., Tugyan K., Ozturk H., Gumustekin M., Cilaker S., Uysal N. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats. Eur. Surg. Res. 2008, 40:354-360.
38. Hakim L.S., Goldstein I. Diabetic sexual dysfunction. Endocrinol. Metab. Clin. N. Am. 1996, 25:379-400.
39. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Clarendon, Oxford, UK. fourth ed.
40. Hara A., Radin N.S. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 1978, 90:420-426.
41. de las Heras A., Schoch A.M., Fischer A. Comparison of methods for determining malondialdehyde in dry sausage by HPLC and the classic TBA test. Eur. Food Res. Technol. 2003, 217:180-184.
42. Hsu P.C., Liu M.Y., Hsu C.C., Chen L.Y., Guo Y.L. Effects of vitamin E and/or C on reactive oxygen species-related lead toxicity in the rat sperm. Toxicology 1998, 128:169-179.
43. Huang Y.S., Horrobin D.F., Manku M.S., Mitchell J., Ryan M.A. Tissue phospholipid fatty acid composition in the diabetic rat. Lipids 1984, 19:367-370.
44. Huang Y.L., Shen C.K., Luh T.Y., Yang H.C., Hwang K.C., Chou C.K. Blockage of apoptotic signaling of transforming growth factor beta in human hepatoma cells by carboxyfullerene. Eur. J. Biochem. 1998, 254:38-43.
45. Jang S.M., Kim M.J., Choi M.S., Kwon E.Y., Lee M.K. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metabolism 2010, 59:512-519.
46. Jelodar G., Khaksar Z., Pourahmadi M. Endocrine profile and testicular histomorphometry in adult rat offspring of diabetic mothers. J. Physiol. Sci. 2009, 59:377-382.
47. Johnsen S.G. Testicular biopsy score count a method for registration of spermatogenesis in human normal values and results in 335 hypogonadal males. Hormones 1970, 1:2-25.
48. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31:671-701.
49. Kolosnjaj J., Szwarc H., Moussa F. Toxicity studies of fullerenes and their derivates. Adv. Exp. Med. Biol. 2007, 620:168-180.
50. Kothari S., Thompson A., Agarwal A., du Plessis S.S. Free radicals: their beneficial and detrimental effects on sperm function. Indian J. Exp. Biol. 2010, 48. 425-35.
51. Kroto H.W., Heath J.R., O'Brien S.C., Curl R.F., Smalley R.E. Buckminsterfullerene. Nature 1985, 318:162-163.
52. Lin H.S., Lin T.S., Lai R.S., D'Rosario T., Luh T.Y. Fullerenes as a new class of radioprotectors. Int. J. Radiat. Biol. 2001, 2:235-239.
53. Lopes S., Jurisicova A., Sun J., Casper R.F. Reactive oxygen species, potential cause for DNA fragmentation in human spermatozoa. Hum. Reprod. 1998, 13:896-900.
54. Lopez-Cervantes J., Sanchez-Machado D.I., Rios-Vazquez N.J. High-performance liquid chromatography method for the simultaneous quantification of retinol, alpha-tocopherol, and cholesterol in shrimp waste hydrolysate. J. Chromatogr. A 2006, 1105:135-139.
55. Lu L.H., Lee Y.T., Chen H.W., Chiang L.Y., Huang H.C. The possible mechanisms of the antiproliferative effect of fullereneol, polyhydroxylated C60, on vascular smooth muscle cells. Br. J. Pharmacol. 1998, 123:1097-1102.
56. Lu Z.H., Mu Y.M., Wang B.A., Li X.L., Lu J.M., Li J.Y., Pan C.Y., Yanase T., Nawata H. Saturated free fatty acids, palmitic acid and stearic acid, induce apoptosis by stimulation of ceramide generation in rat testicular Leydig cell. Biochem. Biophys. Res. Commun. 2003, 303:1002-1007.
57. Mallick C., Mandal S., Barik B., Bhattacharya A., Ghosh D. Protection of testicular dysfunctions by MTEC, a formulated herbal drug, in streptozotocin induced diabetic rat. Biol. Pharm. Bull. 2007, 30:84-90.
58. Miyazaki M., Gomez F.E., Ntambi J.M. Lack of stearoyl-CoA desaturase-1 function induces a palmitoyl-CoA Delta6 desaturase and represses the stearoyl-CoA desaturase-3 gene in the preputial glands of the mouse. J. Lipid Res. 2002, 43:2146-2154.
59. Mirkov S., Djordjevic A., Andric N., Andric S., Kostic T., Bogdanovic G., Vojinovic-Miloradov M., Kovacevic R. Nitric-oxide scavenging activity of polyhydroxylated fullerenol C60(OH)24. Nitric Oxide Biol. Chem. 2004, 11:201-207.
60. Misirkic M.S., Todorovic-Markovic B.M., Vucicevic L.M., Janjetovic K.D., Jokanovic V.R., Dramicanin M.D., Markovic Z.M., Trajkovic V.S. The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene (C(60)) nanoparticles. Biomaterials 2009, 30:2319-2328.
61. Monti D., Moretti L., Salvioli S., Straface E., Malorni W., Pellicciari R., Schettini G., Bisaglia M., Pincelli C., Fumelli C., Bonafè M., Franceschi C. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 2000, 277:711-717.
62. Mori T., Takada H., Ito S., Matsubayashi K., Miwa N., Sawaguchi T. Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology 2006, 225:48-54.
63. Mori T., Ito S., Namiki M., Suzuki T., Kobayashi S., Matsubayashi K., Sawaguchi T. Involvement of free radical followed by the activation of phospholipase A2 in the mechanism that underlies the combined effects of methamphetamine and morphine on subacute toxicity or lethality in mice, comparison of the therapeutic potential of fullerene, mepacrine, and cooling. Toxicology 2007, 236:149-157.
64. Murugan M.A., Gangadharan B., Mathur P.P. Antioxidative effect of fullerenol on goat epididymal spermatozoa. Asian J. Androl. 2002, 4:149-152.
65. Nakamura E., Isobe H. Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. Acc. Chem. Res. 2003, 36:807-815.
66. Navarro-Casado L., Juncos-Tobarra M.A., Cháfer-Rudilla M., de Onzoño L.I., Blázquez-Cabrera J.A., Miralles-García J.M. Effect of experimental diabetes and STZ on male fertility capacity: study in rats. J. Androl. 2010, 31:584-592.
67. Niehaus W.G., Smuelson B. Formation of MDA from phospholipids arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 1968, 6:126-130.
68. Ntambi J.M. The regulation of stearoyl-CoA desaturase (SCD). Prog. Lipid Res. 1995, 34:139-150.
69. Partha R., Conyers J.L. Biomedical applications of functionalized fullerene-based nanomaterials. Int. J. Nanomed. 2009, 4:261-275.
70. Pérez-Matute P., Zulet M.A., Martínez J.A. Reactive species and diabetes: counteracting oxidative stress to improve health. Curr. Opin. Pharmacol. 2009, 9:771-779.
71. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zachary M.D., Remacle J. Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 1990, 51:283-297.
72. Pitteloud N., Hardin M., Dwyer A.A., Valassi E., Yialamas M., Elahi D., Hayes F.J. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J. Clin. Endocrinol. Metab. 2005, 90:2636-2641.
73. Podolski I.Y., Podlubnaya Z.A., Kosenko E.A., Mugantseva E.A., Makarova E.G., Marsagishvili L.G., Shpagina M.D., Kaminsky Y.G., Andrievsky G.V., Klochkov V.K. Effects of hydrated forms of C60 fullerene on amyloid β-peptide fibrillization in vitro and performance of the cognitive task. J. Nanosci. Nanotechnol. 2007, 7:1479-1485.
74. Prato M. Fullerene chemistry for materials science applications. J. Mater. Chem. 1997, 7. 1097-1009.
75. Quick K.L., Ali S.S., Arch R., Xiong C., Wozniak D., Dugan L.L. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol. Ageing 2008, 29:117-128.
76. Romanelli F., Valenca M., Conte D., Isidori A., Negro-Vilar A. Arachidonic acid and its metabolites effects on testosterone production by rat Leydig cells. J. Endocrinol. Invest. 1995, 18:186-193.
77. Ruoff R.S., Tse D.S., Malhotra R., Lorents D.C. Solubility of fullerene (C60) in a variety of solvents. J. Phys. Chem. 1993, 97:3379-3383.
78. Ryan J.J., Bateman H.R., Stover A., Gomez G., Norton S.K., Zhao W., Schwartz L.B., Lenk R., Kepley C.L. Fullerene nanomaterials inhibit the allergic response. J. Immunol. 2007, 179:665-672.
79. Sánchez-Machado D.I., López-Hernández J., Paseiro-Losada P., López-Cervantes J. An HPLC method for the quantification of sterols in edible seaweeds. Biomed. Chromatogr. 2004, 18:183-190.
80. Sánchez-Machado D.I., López-Hernández J., Paseiro-Losada P. High-performance liquid chromatographic determination of alpha-tocopherol in macroalgae. J. Chromatogr. A. 2002, 976(1-2):277-284.
81. Satoh M., Takayanag I. Pharmacological studies on fullerene C60, a novel carbon allotrope, and its derivates. J. Pharm. Sci. 2006, 100:513-518.
82. Scarano W.R., Messias A.G., Oliva S.U., Klinefelter G.R., Kempinas W.G. Sexual behaviour, sperm quantity and quality after short-term streptozotocin-induced hyperglycaemia in rats. Int. J. Androl. 2006, 29:482-488.
83. Schnedl W.J., Ferber S., Johnson S., Newgard C.B. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994, 43:1326-1333.
84. Sheriff D.S. Influence of hormones on testicular lipids of adult rats. Horm. Res. 1980, 13:165-173.
85. Seethalakshmi L., Menon M., Diamond D. The effect of streptozotocin-induced diabetes on the neuroendocrine-male reproductive tract axis of the adult rat. J. Urol. 1987, 138:190-194.
86. Shrilatha B., Muralidhara Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences. Reprod. Toxicol. 2007, 23:578-587.
87. Sivitz W.I., Yorek M.A. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid. Redox Signal. 2010, 12:537-577.
88. Srdjenovic B., Milic-Torres V., Grujic N., Stankov K., Djordjevic A., Vasovich V. Antioxidant properties of fullerenol C60(OH)24 in rat kidneys, testes, and lungs treated with doxorubicin. Toxicol. Mech. Methods 2010, 20:298-305.
89. Sumizawa T., Igisu H. Suppression of acrylamide toxicity by carboxyfullerene in human neuroblastoma cells in vitro. Arch. Toxicol. 2009, 83:817-824.
90. Tan D.X., Reiter R.J. Melatonin mitigates mitochondrial malfunction. J. Pineal Res. 2005, 38:1-9.
91. Tanaka M., Nakaya S., Kumai T., Watanabe M., Matsumoto N., Kobayashi S. Impaired testicular function in rats with diet-induced hypercholesterolmia and/or streptozotocin-induced diabetes mellitus. Endocrinol. Res. 2001, 27:109-117.
92. Tsai M.C., Chen Y.H., Chiang L.Y. Polyhydroxylated C60, fullerenol, a novel free radical trapper, prevented hydrogen peroxide- and cumene hydroxyperoxide-elicited changes in rat hippocampus in vitro. J. Pharm. Pharmacol. 1997, 49:438-445.
93. Türk G., Ateşşahin A., Sönmez M., Çeribaşi A.O., Yüce A. Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid. Fertil. Steril. 2008, 89:1474-1481.
94. Tykhomyrov A.A., Nedzvetsky V.S., Klochkov V.K., Andrievsky G.V. Nanostructures of hydrated C60 fullerene (C60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals. Toxicology 2008, 246:158-165.
95. Valk E.E., Hornstra G. Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man, a review. J. Vit. Nutr. Res. 2000, 70:31-42.
96. Wang X., Sharma R.K., Gupta A., George V., Thomas A.J., Falcone T., Ararwal A. Alterations in mitochondria membrane potential and oxidative stress in infertile men, a prospective observational study. Fertil. Steril. 2003, 80:844-850.
97. Waterman M.R., Keeney D.S. Genes involved in androgen biosynthesis and the male phenotype. Horm. Res. 1992, 38:217-221.
98. Wilder P.J., Coniglio J.G. The effects of streptozotocin diabetes and of dietary protein content on the composition and metabolism of testicular lipids. Proc. Soc. Exp. Biol. Med. 1984, 177:399-405.
99. Williams G., Pickup J.C. Handbook of Diabetes 2004, Blackwell, Oxford.
100. Yin F.Q., Chen Q., Sprecher H. A comparison of the metabolism of [3-14C]-labeled 22- and 24-carbon (n-3) and (n-6) unsaturated fatty acids by rat testes and liver. Biochim. Biophys. Acta 1999, 1438:63-72.
101. Yudoh K., Karasawa R., Masuko K., Kato T. Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis. Int. J. Nanomed. 2009, 4:217-225.
102. Zhao H., Xu S., Wang Z., Li Y., Guo W., Lin C., Gong S., Li C., Wang G., Cai L. Repetitive exposures to low-dose X-rays attenuate testicular apoptotic cell death in streptozotocin-induced diabetes rats. Toxicol. Lett. 2010, 192:356-364.
103. Zhou Z., Lenk R., Dellinger A., MacFarland D., Kumar K., Wilson S.R., Kepley C.L. Fullerene nanomaterials potentiate hair growth. Nanomedicine 2009, 5:202-207.
104. Zhu J., Ji Z., Wang J., Sun R., Zhang X., Gao Y., Sun H., Liu Y., Wang Z., Li A., Ma J., Wang T., Jia G., Gu Y. Tumor-inhibitory effect and immunomodulatory activity of fullerol C60(OH)x. Small 2008, 4:1168-1175.